查詢結果分析
來源資料
相關文獻
- Primary Radiotherapy Treatment Results of Maxillary Sinus Squamous Cell Carcinoma
- Definitive Radiotherapy with Or Without Chemotherapy for Resectable Head and Neck Cancer
- Post-Operative Combination of Radiotherapy and Chemotherapy in Esophageal Cancer
- Radiotherapy for Squamous Cell Carcinoma of the Maxillary Sinus
- Postoperative Radiotherapy of Adult Supratentorial High-grade Astrocytoma
- Malignant Primary Extragonadal Germ Cell Tumors of Mediastinum--An Analysis of Clinical and Radiological Features in 15 Cases
- Radiation Therapy in Primary Central Nervous System Lymphoma
- Implications of a Failed Prospective Trial of Adjuvant Therapy after Radical Hysterectomy for Stage Ib-IIa Cervical Carcinoma with Pelvic Node Metastases
- 攝護腺癌之傳統放射線治療--長庚紀念醫院十四年之經驗
- Preoperative Radiotherapy in Patients with Lower Rectal Cancer:Results of Sphincter-Preservation, Treatment Outcome and Morbidities
頁籤選單縮合
題名 | Primary Radiotherapy Treatment Results of Maxillary Sinus Squamous Cell Carcinoma=上頷竇扁平細胞癌之放射治療結果 |
---|---|
作者 | 許智捷; 雷德; 鍾娜娜; 丁禮莉; 邵文逸; | 書刊名 | 放射治療與腫瘤學 |
卷期 | 5:3 1998.09[民87.09] |
頁次 | 頁163-170 |
分類號 | 416.871 |
關鍵詞 | 放射治療; 合併治療; 上頷竇; 扁平細胞癌; Radiotherapy; Combined treatment; Maxillary sinus; Squamous cell carcinoma; |
語文 | 英文(English) |
中文摘要 | 目的:評估上頷竇癌用不同治療方式後的結果。 材料與方法:從1977至1991年61個上頷竇扁平細胞癌中,有11個病人(18%)是T3,50個病 人(82%)是T4。其中18個病人只作放射治療,32個病人術後追加放射治療,11個病人合併放 射治療,竇造口術及動脤內注射化學治療。 結果:以上三組病人五年存活率分別為5.6%,34.4%及54.5%,具有明顯統計差別。在診斷時 有淋巴轉移的病人,其五年存活率較無淋巴轉移病人明顯偏低(7.1%比36.2%)。多變數分析 得出性別,治療方式,淋巴分期為顯著的預後因子。 結論:合併治療比只作放射治療有較好的五年存活率。 |
英文摘要 | Purpose: Evaluating 5-year survival rates of maxillary sinus squamous cell carcinoma treated by different methods. Materials and Methods: From 1977 to 1991, 61 patients of maxillary sinus squamous cell carcinoma were included in our study. There were 11 patients with T3 (18%) disease and 50 patients with T4 (82%) disease. Eighteen patients (29.5%) were treated by radiotherapy alone (RT), 32 patients (52.5%) by combined surgery and radiotherapy (SRT) and 11 patients (18.0%) by combined radiotherapy with intra-arterial 5-FU infusion chemotherapy and antrostomy drainage (CRT). Results: Five-year survival rates were 5.6%, 34.4% and 54.5% in RT, SRT and CRT groups, respectively. Statistical significant difference (p<0.05) of survival rates was noted. Regional neck nodal metastasis at initial diagnosis carried significant worse survival results than initial NO state (7.1% vs. 36.2%, p=0.0003). Multivariate analysis revealed that treatment methods, sex and N stages significantly influenced the 5-year survival rate. Conclusion: Combined treatment was superior to radiotherapy alone in 5-year survival rates. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。